PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50125C00006OXIVAX - AOI #28: influenza vaccine — Osivax

Osivax holds $20.2M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Mar 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma
Awarding office
Osivax
Recipient
Mar 31, 2027
PoP end
$744K
Obligated
$744K
Potential
541714
NAICS
AN14
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75A50125C00006
AgencyBarda - Aspr / Daappo / Barda Dcma
Awarding officeBarda - Aspr / Daappo / Barda Dcma
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentOsivax
CAGEFBDR2
UEIM4YDKJJRJYC7
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN14
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startSep 30, 2025
PoP end (current)Mar 31, 2027
Obligated$744K
Current value$744K
Potential value$744K

OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQUENCING BASED AGNOSTIC DIAGNOSTICS FOR VIRAL PATHOGENS THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PREPARE THE IND PACKAGE FOR OVX836+SQ ADJUVANT. is a federal Unrestricted award for Barda - Aspr / Daappo / Barda Dcma held by Osivax. Estimated value $744K ($744K obligated). Current period of performance ends Mar 31, 2027. Last award drew 1 bidder.

OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQUENCING BASED AGNOSTIC DIAGNOSTICS FOR VIRAL PATHOGENS THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PREPARE THE IND PACKAGE FOR OVX836+SQ ADJUVANT.

Recompete timing

Public
● Expiring in 185 days

Current PoP ends Mar 31, 2027 (185 days remaining). Agencies typically plan 12–18 months ahead — at 6.1 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75A50125C00006? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Osivax — $20.2M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$20.2M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
75A50125C00008
OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A…
$19.5M
Jul 24, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50125C00006?

75A50125C00006 (OXIVAX - AOI #28: influenza vaccine) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $744K, currently held by Osivax. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50125C00006?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50125C00006 to Osivax (potential $744K).

Who is the incumbent on 75A50125C00006?

Osivax is the incumbent with $20.2M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2027.

When does Osivax’s 75A50125C00006 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50125C00006? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50125C00006